Fibrosis-4 Model Influences Results of Patients with Hepatocellular Carcinoma Undergoing Hepatectomy

Figure 3

The 1-year, 3-year, and 5-year disease-free survival between fibrosis-4 ≥3.15 group and fibrosis-4<3.15 group. Worse disease-free survival was also observed in the fibrosis-4 ⩾3.15 group; the corresponding 1-year, 3-year, and 5-year disease-free survival were 74.9%, 45.3%, and 24.6% for fibrosis-4 ⩾3.15 group and 81.8%, 54.9%, and 34.4% for the fibrosis-4<3.15 group (P=0.009).